Resultados de Búsqueda
It is uncertain that Extracorporeal Membrane Oxygenation (ECMO) is effective in reducing mortality in patients with Acute Respiratory Failure.
Evidencias COVID-19
Coronavirus (COVID-19): Evidence Collection. Evidence Aid
Some patients with COVID-19 will become critically ill and need help with their breathing. Extracorporeal membrane oxygenation (ECMO) is a form of life support that targets the heart and lungs and which might be used for them. In this Cochrane systematic review, the authors searched for randomized and quasi-randomized trials testing the use of ECMO for acute respiratory failure. It is uncertain whether ECMO is, or is not, more effective than conventional lung support in reducing mortality ...
ver más ... 2020There is uncertainty about the effects of enteral and parenteral nutrition and their combination on sepsis and hospital mortality.
Evidencias COVID-19
Coronavirus (COVID-19): Evidence Collection. Evidence Aid
Some patients with COVID-19 will become critically ill and need treatment in an intensive care unit (ICU). This may interrupt their feeding routines and reduce appetite or increase nausea and vomiting, leading to malnutrition. In this Cochrane systematic review, the authors searched for randomized trials and quasi-randomized trials comparing enteral nutrition (EN), parenteral nutrition (PN) and the combination in adult ICU patients. There is low certainty evidence that enteral nutrition may ...
ver más ... 2020Upon presentation of ST segment elevation myocardial infarction (STEMI) and COVID-19, clinicians should weigh the risks and severity of STEMI against the potential severity of COVID-19 infection for ...
Evidencias COVID-19
Centro Cochrane Iberoamericano
Decisions about the primary performance of a percutaneous coronary intervention or fibrinolytic therapy should be informed from this assessment for patients with COVID-19 and acute coronary syndrome (ACS).
ver más ... 2020Prophylactic anticoagulation should be administered in patients with moderate or severe COVID-19 and with DIC, but without obvious bleeding.
Evidencias COVID-19
Centro Cochrane Iberoamericano
-In patients with moderate or severe COVID-19 and with suspicion or confirmation of DIC, but without evident bleeding, there are insufficient data to consider the routine use of parenteral anticoagulation treatment with therapeutic or intermediate doses with unfractionated heparin or heparin. low molecular weight. -In patients with moderate or severe COVID-19 and on chronic anticoagulation treatment with suspected or confirmed DIC without obvious bleeding, it would be reasonable to consider the ...
ver más ... 2020Risk stratification should be performed to decide on VTE prophylaxis in patients admitted with moderate or severe COVID-19 without disseminated intravascular coagulation (DIC).
Evidencias COVID-19
Centro Cochrane Iberoamericano
In patients admitted with COVID-19 without DIC, prophylactic doses of anticoagulants can be administered to prevent VTE. If pharmacological prophylaxis is contraindicated, it is recommended to consider intermittent mechanical compression. In patients admitted with COVID-19 without DIC, there is insufficient data to consider routine use with therapeutic or intermediate doses of parenteral anticoagulation with unfractionated heparin or low molecular weight heparin. Routine screening for VTE ...
ver más ... 2020